Table.
before the treatment | before starting the third treatment | before the treatment | before starting the third treatment | before the treatment | before starting the third treatment | |||||
---|---|---|---|---|---|---|---|---|---|---|
White Blood Cells | 52.7×102/μL | 58×102/μL | TP | 7.1 g/dL | 7.7 g/dL | cryoglobulins | - | ND | ||
Neu | 47.8% | 48.6% | Alb | 4.2 g/dL | 4.3g/dL | free light chain κ/λ | ND | 0.75 | ||
Ly | 35.9% | 38.1% | BUN | 12.7 mg/dL | 14.3 mg/dL | M protein | - | - | ||
Mon | 5.5% | 5.7% | Cr | 0.83 mg/dL | 1.57mg/dL* | ANA speckled pattern | 1:40* | - | ||
Eo | 10.2%* | 6.4% | eGFR | 57.2 mL/min/1.73m2* | 27.3mL/min/1.73m2* | ANA cytoplasmic pattern | 1:40* | 1:40* | ||
Ba | 0.6% | 1.2% | UA | 1.5 mg/dL* | 1.8mg/dL* | SS-A Ab | ≤7.0U/mL | ND | ||
Red Blood Cells | 417×104/μL | 357×104/μL | AST | 25 IU/L | 15 IU/L | SS-B Ab | ≤7.0U/mL | ND | ||
Hb | 12.8 g/dL | 11.4 g/dL* | ALT | 33 IU/L | 11 IU/L | antimitochondrial M2 Ab | ND | 141U/mL* | ||
Ht | 40.2% | 36.5% | ALP | 725 IU/L* | 673 IU/L* | TSH | 0.824μIU/mL | 0.736μIU/mL | ||
platelet | 22.1×104/μL | 23.3×104/μL | ALP-2 34% | ALP-1 3% | free T4 | 0.97ng/dL | 1.01ng/dL | |||
PT-INR | 0.88 | 0.95 | ALP-3 66% | ALP-2+3 97% | ||||||
APTT | 25.5 sec | 27.0 sec | T-Bil | 0.8mg/dL | 0.7mg/dL | Urinalysis | ||||
γGTP | 25 IU/L | 13 IU/L | pH | 7.5* | 8.5* | |||||
arterial blood gas (at rest) | LDH | 168 IU/L | 182 IU/L | Protein | 1.4 g/ gCr* | 2.6 g/gCr* | ||||
pH | 7.323 | ND | T-Cho | 200mg/dL | ND | alb | 29.3% | ND | ||
PCO2 | 39.0 mmHg | ND | LDL-C | 95mg/dL | 90mg/dL | α1-glb | 11.0% | ND | ||
PO2 | 69.9 mmHg* | ND | Na | 140mEq/L | 141mEq/L | α2-glb | 23.2% | ND | ||
HCO3- | 19.6 mEq/L* | ND | K | 3.7mEq/L | 3.3mEq/L* | β2-glb | 22.4% | ND | ||
A-aDO2 | 31.4 mmHg* | ND | CL | 111mEq/L* | 108mEq/L | γ-glb | 14.1% | ND | ||
SpO2 | 94.50% | ND | Ca | 8.7mg/dL | 9.8mg/dL | Sugar | 2+* | 4+* | ||
P | 2.3mg/dL* | 1.6mg/dL* | 696mg/dL* | |||||||
HBs Ag | 0.00 IU/mL | 0.00 IU/mL | CRP | 0.01mg/dL | 0.02mg/dL | Red Blood Cells | 1.3 /HPF | 1.2 /HPF | ||
HCV Ab -II | 0.07 S/CO | 0.05 S/CO | GLU | 95mg/dL | 93mg/dL | White Blood Cells | 2.9/HPF | 2.4/HPF | ||
HBs Ab | ND | 0.1 mIU/mL | HbA1c (NGSP) | 5.0% | 5.4% | Granular casts | +* | - | ||
HBc Ab | ND | 0.05 S/CO | Magnesium | 2.6mg/dL | 2.7mg/dL* | Epithelial cell casts | +* | - | ||
HIV Ab | ND | 0.1 S/CO | Aluminum | ≤10μg/L | ND | generalized aminoaciduria | ND | +* | ||
PTH-intact | 24.3pg/mL | 52.0pg/mL | NAG | 9.0 U/L* | 8.0 U/L* | |||||
interferon-gamma release assays | - | - | 1, 25 (OH)2VD3 | ND | 26.8pg/mL | β2MG | 14,774μg/L* | 64,978μg/L* | ||
sputum culture | no particular findings | ND | IgG | 1,022mg/dL | 837mg/dL* | Bence Jones protein | - | ND | ||
IgA | 262mg/dL | 261mg/dL | Na | 57mEq/L | 56mEq/L | |||||
IgM | 630mg/dL* | 637mg/dL* | K | 21mEq/L | 63.2mEq/L | |||||
IgG4 | 14.0mg/dL | ND | CL | 44mEq/L | 31mEq/L | |||||
C3 | 75mg/dL* | 88.3mg/dL* | urine Ca/Cr ratio | ND | 0.21* | |||||
C4 | 18mg/dL | 20.9mg/dL | ||||||||
FEHCO3- | ND | 8.0%* | ||||||||
(after loading bicarbonate) | ||||||||||
FEP | ND | 56.6%* | ||||||||
%TRP | ND | 43.4%* | ||||||||
TmP/GFR | ND | 0.95mg/dL* | ||||||||
FEUA | 34.1%* | 75.6%* | ||||||||
FEK | 12%* | 105.1%* |
Asterisks (*) indicate abnormal values.
A-aDO2: alveolar-arterial oxygen difference, Ab: antibody, Ag: antigen, Alb: albumin, ALP: alkaline phosphatase, ALT: alanine aminotransferase, ANA: antinuclear antibody, APTT: activated partial thromboplastin time, AST: aspartate aminotransferase, Ba: basophils, β2MG: beta-2 microglobulin, BUN: blood urea nitrogen, Cr: creatinine, CRP: C-reactive protein, eGFR, estimated glomerular filtration rate, Eo: eosinophils, FECHO3-: fractional excretion of bicarbonate, FEK: fractional excretion of potassium, FEP: fractional excretion of phosphate, FEUA: fractional excretion of uric acid, glb: globulin, GLU: casual blood glucose, γGTP: gamma-glutamyl transpeptidase, Hb: hemoglobin, HBc: hepatitis B core, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, Ht: hematocrit, Ig: immunoglobulin, LDH: lactate dehydrogenase, LDL-C: low-density lipoprotein cholesterol, Ly: lymphocytes, Mon: monocytes, NAG: N-acetyl-beta-D-glucosaminidase, ND: no data, Neu: neutrophils, NGSP: National Glycohemoglobin Standardization Program, PTH: parathyroid hormone, PT-INR: prothrombin time-international normalized ratio, SpO2: saturation of percutaneous oxygen, T-Cho: total cholesterol, T-Bil: total-bilirubin, TP: total protein, TRP: tubular re-absorption of phosphate, TSH: thyroid-stimulating hormone, TmP/GFR: tubular maximum of phosphate, T4: thyroxine 4, UA: uric acid, 1, 25 (OH)2VD3: 1, 25- dihydroxy vitamin D3